Clinical Trial Update: Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial by Mayo Clinic investigating insulin receptor substrate 1 (IRS-1) regulation in insulin resistance in Type 2 Diabetes Mellitus, which h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mayo Clinic | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED